Seeking Alpha

  Intelsat SA - NYSE

10/30/2014, 8:02 PM ET
  • Michael Bryant | Send Message 3 Oct 2012

    I have to agree with Cramer, Sarepta Therapeutics' (SRPT) orphan drug status could be a huge advantage. http://bit.lyPxXDwC__source=yahoo|headline|quote|video|&par=yahoo
    Reply (5)
  • View all 5 replies
    • Michael Bryant | Send Message 3 Oct 2012
      : Truffel: Yup, few patients, but you get federal help and a lot of exclusivity.
    • TruffelPig | Send Message 3 Oct 2012
      : Thanks for clarification on this.
      I vs. ETF Alternatives
      Company Description
      Intelsat SA provides satellite services. The Company offers satellite services to media companies, fixed and wireless telecommunications operators, data networking service providers for enterprise and mobile applications, multinational corporations.